Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease
- PMID: 17378733
- DOI: 10.1515/CCLM.2007.061
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease
Abstract
Background: The levels and fine structure of complex polysaccharides, glycosaminoglycans (GAGs), were determined in segments of the posterior mitral valve leaflet (MVL) taken from 15 patients affected by mitral regurgitation and degenerative disease and were compared with segments from 15 multiorgan donors.
Methods: MVL GAGs were analyzed by agarose gel electrophoresis, and by HPLC and fluorophore-assisted carbohydrate electrophoresis to evaluate disaccharide patterns after treatment with chondroitinase ABC.
Results: GAGs from the control group were composed of approximately 37% hyaluronic acid and 63% chondroitin sulfate/dermatan sulfate with a charge density of approximately 0.61. Chondroitin sulfate/dermatan sulfate polymers contained approximately 23% of the disaccharide sulfated in position 6 on N-acetyl-galactosamine, approximately 38% of the 4-sulfated disaccharide and approximately 2% of the non-sulfated disaccharide (with a 4-sulfated/6-sulfated ratio of 1.7). The total amount of GAGs was 0.66 microg/mg tissue. The total amount of GAGs in patients suffering from mitral regurgitation and degenerative disease was approximately 51.5% higher (although the difference was not significant, probably because of the low number of subjects enrolled in the study). However, significantly higher hyaluronic acid content (approx. +38%, p<0.05) and lower sulfated GAG content (approx. -21%, p<0.005) were demonstrated. As a consequence, the total charge density decreased by approximately 23% (p<0.005). This macro-modification of GAG composition was also followed by a micro-alteration of the structure of the sulfated polysaccharides, in particular with a significant decrease in the 4-sulfated disaccharide (and a parallel increase in hyaluronic acid content) with no modification of the percentage of the 6-sulfated and non-sulfated disaccharides (with a significant decrease in the 4-/6-sulfated ratio).
Conclusions: We assume that changes in the relative amount and distribution of GAGs in posterior MVL in subjects suffering from mitral regurgitation and degenerative disease are consistent with a decrease in the tension to which these tissues are subjected and with an abnormal matrix microstructure capable of influencing the hydration and of conditioning the mechanical weakness of these pathological tissues.
Similar articles
-
Aortic valve leaflet glycosaminoglycans composition and modification in severe chronic valve regurgitation.J Heart Valve Dis. 2013 Jul;22(4):484-90. J Heart Valve Dis. 2013. PMID: 24224410
-
Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.Anal Biochem. 1999 Sep 10;273(2):229-39. doi: 10.1006/abio.1999.4218. Anal Biochem. 1999. PMID: 10469494
-
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All.J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 5;820(1):131-5. doi: 10.1016/j.jchromb.2005.03.028. Epub 2005 Apr 18. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15866501
-
Implementation of infrared and Raman modalities for glycosaminoglycan characterization in complex systems.Glycoconj J. 2017 Jun;34(3):309-323. doi: 10.1007/s10719-016-9743-6. Epub 2016 Dec 7. Glycoconj J. 2017. PMID: 27928742 Free PMC article. Review.
-
The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics.Microorganisms. 2017 Aug 28;5(3):51. doi: 10.3390/microorganisms5030051. Microorganisms. 2017. PMID: 28846656 Free PMC article. Review.
Cited by
-
The mechanisms, diagnosis and management of mitral regurgitation in mitral valve prolapse and hypertrophic cardiomyopathy.Discoveries (Craiova). 2016 Jun 30;4(2):e61. doi: 10.15190/d.2016.8. Discoveries (Craiova). 2016. PMID: 32309580 Free PMC article. Review.
-
Mitral valve disease--morphology and mechanisms.Nat Rev Cardiol. 2015 Dec;12(12):689-710. doi: 10.1038/nrcardio.2015.161. Epub 2015 Oct 20. Nat Rev Cardiol. 2015. PMID: 26483167 Free PMC article. Review.
-
Cellular mechanisms in mitral valve disease.J Cardiovasc Transl Res. 2011 Dec;4(6):702-9. doi: 10.1007/s12265-011-9318-7. Epub 2011 Sep 3. J Cardiovasc Transl Res. 2011. PMID: 21892743 Review.
-
Characterization of Degenerative Mitral Valve Disease: Differences between Fibroelastic Deficiency and Barlow's Disease.J Cardiovasc Dev Dis. 2021 Feb 22;8(2):23. doi: 10.3390/jcdd8020023. J Cardiovasc Dev Dis. 2021. PMID: 33671724 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials